Premium
Oesophageal diameter is associated with severity but not progression of systemic sclerosis‐associated interstitial lung disease
Author(s) -
Winstone Tiffany A.,
Hague Cameron J.,
Soon Jeanette,
Sulaiman Nada,
Murphy Darra,
Leipsic Jonathon,
Dunne James V.,
Wilcox Pearce G.,
Ryerson Christopher J.
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13309
Subject(s) - medicine , hiatal hernia , gastroenterology , interstitial lung disease , fibrosis , vital capacity , disease , lung , diffusing capacity , reflux , lung function
Background and objective It is unknown whether oesophageal disease is associated with systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) severity, progression or mortality. Methods High‐resolution computed tomography (HRCT) scans from 145 SSc‐ILD patients were scored for fibrosis score, oesophageal diameter and presence of hiatal hernia. Fibrosis asymmetry was calculated as: (most affected side − least affected side)/(most affected side + least affected side). Mixed effects models were used for repeated measures analyses. Results Mean fibrosis score was 8.6%, and most patients had mild‐to‐moderate physiological impairment. Every 1 cm increase in oesophageal diameter was associated with 1.8% higher fibrosis score and 5.5% lower forced vital capacity (FVC; P ≤ 0.001 for unadjusted and adjusted analyses). Patients with hiatal hernia had 3.9% higher fibrosis score, with persistent differences on adjusted analysis ( P = 0.001). Oesophageal diameter predicted worsening fibrosis score over the subsequent year ( P = 0.02), but not when adjusting for baseline fibrosis score ( P = 0.16). Oesophageal diameter was independently associated with mortality ( P = 0.001). Oesophageal diameter was not associated with asymmetric disease or radiological features of gross aspiration. Conclusion Oesophageal diameter and hiatal hernia are independently associated with SSc‐ILD severity and mortality, but not with ILD progression or asymmetric disease. Oesophageal disease is unlikely to be a significant driver of ILD progression in SSc.